Brucellosis Vaccine Market

Brucellosis Vaccine Market – Type (RB51, S19, B19 vaccines), Vaccine (DNA, Subunit, Vector Vaccines), Animal Type (Cattle, Sheep, Goat), End-user (Veterinary Clinics & Hospitals, Animal Care Centers), Global Forecast (2024 – 2032)

Published Date: May - 2025 | Publisher: MIR | No of Pages: 240 | Industry: Animal Health and Nutrition | Format: Report available in PDF / Excel Format

View Details Buy Now 2890 Download Free Sample Ask for Discount Request Customization

Brucellosis Vaccine Market Size

With USD 242.4 million in market size in 2023 and expected to rise at CAGR of 4.9%, brucellosis vaccination market is expected to reach The growing frequency of brucellosis in cattle is one of the main causes since it causes notable financial losses in the agricultural sector.

To get key market trends

  Download Free Sample

Furthermore increasing demand for brucellosis vaccines is growing knowledge among farmers and veterinarians about the need of vaccination. Additionally driving market expansion are government projects and initiatives meant to control and eradicate brucellosis. Moreover, developments in vaccination development technologies—such as recombinant DNA technology—are predicted to inspire creativity in the brucellosis vaccination market, so producing more safe and effective vaccines and so increasing the market growth.

Designed to prevent brucellosis, a bacterial infection brought on by several species of Brucella bacteria, including Brucella abortus, Brucella melitensis, and Brucella suis, brucellosis vaccines are a class of animal vaccinations Veterinary medicine mostly uses these vaccinations to guard cattle, goats, sheep, and pigs from illness transmission.

Brucellosis Vaccine Market Report Attributes
Report Attribute Details
Base Year 2023
Brucellosis Vaccine Market Size in 2023 USD 242.4 Million
Forecast Period 2024 to 2032
Forecast Period 2024 to 2032 CAGR 4.9%
2032 Value Projection USD 370.7 Million
Historical Data for 2021 - 2023
No. of Pages 154
Tables, Charts & Figures 274
Segments covered Type, Vaccines, Animal type, End-user, and Region
Growth Drivers
  • Increasing prevalence of brucellosis
  • Increasing livestock production
  • Rising awareness about zoonotic diseases
Pitfalls & Challenges
  • Stringent regulatory requirements for animal vaccines

What are the growth opportunities in this market?

 Download Free Sample

Brucellosis Vaccine Market Trends

  • Rising global demand for animal products including meat, milk, and dairy drives the increase in cattle output, so generating a sizable market for brucellosis vaccines. Larger cattle herds increase the danger of brucellosis transmission, hence vaccination is an absolutely vital preventive action.
  • To protect their herds and guarantee the viability of their operations, livestock farmers are spending more and more in disease preventive measures like vaccination. This trend drives demand for brucellosis vaccinations, therefore stimulating market expansion.
  • Apart from major financial losses to cattle growers, brucellosis outbreaks generate public health issues because of their zoonotic character.
  • Therefore, the need of implementing efficient vaccination campaigns and control strategies increases as the frequency of brucellosis keeps rising, therefore driving the market development.

Brucellosis Vaccine Market Analysis

Learn more about the key segments shaping this market

 Download Free Sample

Based on type, the market is segmented into RB51 vaccines, S19 vaccines, B19 vaccines, and other types. The RB51 vaccines segment dominated the market with 43.7% of market share in 2023.

  • RB51 vaccine has demonstrated high efficacy in protecting against brucella abortus infection in cattle. Studies have shown that RB51 vaccination significantly reduces the risk of abortion and transmission of brucella abortus to other animals, making it a preferred choice among livestock producers and veterinarians.
  • In addition to this, RB51 vaccine provides long-lasting immunity and is considered safer than the older S19 vaccine, leading to high adoption of this vaccine, thereby fostering the growth of this segment.

Based on vaccine, the brucellosis vaccine market is classified into DNA vaccines, subunit vaccines, vector vaccines, and recombinant vaccines. The DNA vaccines segment held highest market share and is anticipated to grow at CAGR of 4.8% over the forecast period.

  • The DNA vaccines segment has emerged as the dominant segment in the market, largely due to its innovative technology and exceptional performance.
  • Owing to several advantages it offers including high immunogenicity, safety, and potential for cross-protection against diverse brucella species or strains, propels the growth of this segment.
     
  • Moreover, DNA vaccines boast excellent stability and long shelf-life, making them convenient for storage, transportation, and administration in various environmental conditions. Thereby, significantly driving the growth of this segment.

Learn more about the key segments shaping this market

 Download Free Sample

Based on animal type, the brucellosis vaccine market is divided into cattle, sheep, goat, and other animal types. The cattle segment accounted for significant market share and is anticipated to reach USD 216.7 million by 2032.

  • The economic value of cattle in worldwide food production, their great sensitivity to brucella abortus infections, the zoonotic character of brucellosis, and legislative requirements demanding vaccination help to explain the predominance of the cattle segment in the market.
  • Preventing brucellosis in cattle is essential since they act as a reservoir for brucella abortus and there is a chance of transfer to people, thereby helping this section to flourish.

Based on end-user, the brucellosis vaccine market is categorized into veterinary clinics & hospitals, animal care centers, and other end-users. The veterinary clinics & hospitals segment was valued at USD 146.4 million in 2023.

  • The veterinary clinics & hospitals segment dominated the market due to its pivotal role as a centralized hub for vaccine distribution, administration, and expertise.
  • These facilities serve as trusted sources of veterinary advice and guidance, offering specialized knowledge on disease prevention, including brucellosis vaccination protocols.
  • Moreover, veterinary clinics and hospitals provide convenient access to brucellosis vaccination services, particularly in rural and remote areas where access to veterinary care may be limited, through vaccination clinics, mobile veterinary services, and on-farm visits.

Looking for region specific data?

 Download Free Sample

North America brucellosis vaccine market was valued at USD 99.4 million in 2023 and is predicted to reach USD 150.7 million by the end of the forecast timeframe.

  • North America boasts a sizable cow population, especially among extremely sensitive to brucella abortus infected species.
  • Large cattle herds in nations like the United States and Canada increase the danger of brucellosis transmission, hence broad vaccination is necessary to stop disease outbreaks and financial losses in the cattle sector.
  • Advanced veterinary infrastructure—including established veterinary clinics, hospitals, and diagnostic labs appropriate to manage brucellosis vaccination campaigns—helps the area as well.

U.S. brucellosis vaccine market is anticipated to witness growth at 4.7% CAGR over the forecast years.

  • The U.S. has stringent regulatory standards for animal health and food safety enforced by agencies such as the United States Department of Agriculture (USDA) and the Animal and Plant Health Inspection Service (APHIS).
  • Regulatory mandates and vaccination requirements compel livestock producers to prioritize brucellosis vaccination to maintain market access, ensure compliance with regulatory standards, and meet export requirements.
  • Furthermore, the U.S. leads in technological advancements in vaccine development, research, and innovation. Ongoing investments in research and development drive the development of novel vaccine formulations, delivery systems, and vaccination strategies, enhancing the efficacy and safety of brucellosis vaccines in the US market. Such aforementioned factors boost the growth of this market.

Germany held a significant position in global brucellosis vaccine market.

  • The National Institutes of Health estimate that of Germany's 0.38/1,000,000 population annual brucellosis incidence, 75% are travel related. Aiming to preserve cattle populations and reduce the risk of zoonotic transmission to people, Germany gives brucellosis prevention top priority in its public health campaigns given the rising incidence of the disease.
  • Furthermore influencing the development of the market in Germany are elements including superior veterinary infrastructure, rigorous regulatory standards, high cattle density, and technological developments.

India market is predicted to witness growth at considerable growth rate during the forecast period.

  • According to 20th Livestock Census, total livestock population in India were 535.78 million in 2019. Of which total number of cattle in the country were 192.49 million in 2019.
  • This large livestock population, particularly the significant number of cattle, in India acts as a key driver in the market, highlighting the importance of vaccination efforts to safeguard animal health, ensure food security, and mitigate economic losses in the agricultural sector.

Brucellosis Vaccine Market Share

Comprising multiple major competitors including pharmaceutical corporations, biotechnology companies, and veterinary vaccine producers, the brucellosis vaccine market is rather competitive. By means of research, development, manufacturing, and distribution of brucellosis vaccines, these companies aim to acquire market share and preserve competitiveness by means of innovation, strategic alliances, and regulatory compliance.

Brucellosis Vaccine Market Companies

Prominent players operating in the brucellosis vaccine industry include

Brucellosis Vaccine Industry News

  • Hester Biosciences signed a contract in September 2020 to buy indigenous technology from ICAR-IVRI (Indian Council of Agricultural Research - Indian Veterinary Research Institute) for the Brucella Abortus S19 Delta Per vaccination development. This calculated move enabled the business to increase the range of products they offer and create income.

The brucellosis vaccine market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments

Click here to Buy Section of this Report

Market, By Type

  • RB51 vaccines
  • S19 vaccines
  • B19 vaccines
  • Other types

Market, By Vaccine

  • DNA vaccines
  • Subunit vaccines
  • Vector vaccines
  • Recombinant vaccines

Market, By Animal Type

  • Cattle
  • Sheep
  • Goat
  • Other animal type

Market, By End-user

  • Veterinary clinics & hospitals
  • Animal care centers
  • Other end-users

The above information is provided for the following regions and countries

  • North America
    • U.S.
    • Canada 
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Netherlands
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East and Africa

 

Related Reports

Table of Content

Will be Available in the sample /Final Report. Please ask our sales Team.

Will be Available in the sample /Final Report. Please ask our sales Team.

FAQ'S

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@marketinsightsresearch.com

Within 24 to 48 hrs.

You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email